Whole blood RNA-seq data of SPMS vs RRMS patients from paper titled \"Relapsing remitting and secondary progressive multiple sclerosis are characterised by distinct metabolomic and transcriptomic signatures that could aid patient management strategies\"

We combined analysis of serum metabolomics and whole blood transcriptomics in patients with RRMS and SPMS to build an integrated network describing these different phases of MS and to help improve our understanding of the potential mechanisms driving disease progression. Transcriptomic analysis of whole blood was performed to assess differential gene expression between five patients with RRMS and eight patients with SPMS.